US · Healthcare

Rapid Dose Therapeutics Corp (RDTCF)

Biotechnology

Rapid Dose Therapeutics Corp (RDTCF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RDTCF

P/E ratio

25.00

Rapid Dose Therapeutics Corp (RDTCF) — FAQ

What is RDTCF's P/E ratio?

The price-to-earnings (P/E) ratio for Rapid Dose Therapeutics Corp (RDTCF) is 25.00 (data as of 2026-05-23).

Does Rapid Dose Therapeutics Corp pay a dividend?

Dividend yield is not available in the current snapshot for Rapid Dose Therapeutics Corp (RDTCF). Check the MyAverix Finance app for the latest dividend data.

What sector is Rapid Dose Therapeutics Corp in?

Rapid Dose Therapeutics Corp (RDTCF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is RDTCF listed on?

RDTCF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)